IRCT20210317050737N1

Comparison of intravenous and intermittent furosemide injection on pulmonary status and heart failure of newborns

Comparison of the effects of continuous versus bolus intermittent Furosemide infusion on the pulmonary status and, hemodynamic responses in neonates with congestive heart failure
Kerman University of Medical Sciences·Phase 2·Iranian Registry Of Clinical TrialSuspended
Study focus
Disease/Condition
Heart failure
Study type
Interventional
Sponsor & location
Primary sponsor
Kerman University of Medical Sciences
Location
Iran
Timeline & enrollment
Phase
Phase 2
Start date
Jan 21, 2023
End date
N/A
ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureHypertensive heart disease with (congestive) heart failureLeft ventricular failure
Data source
Registry
Iranian Registry Of Clinical Trial
Trial ID
IRCT20210317050737N1
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for IRCT20210317050737N1 through Pure Global AI's free database. This Phase 2 trial is sponsored by Kerman University of Medical Sciences and is currently Suspended. The study focuses on Heart failure.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.